Skin diseases associated with hepatitis C virus infection
Stephanos J. Hadziyannis
Academic Department of Medicine, Hippokration General Hospital, 114 Vas. Sophias Ave., 115 27 Athens, Greece
Tel.: +30 1 7774742; fax: +30 1 7706871.
Search for more papers by this authorStephanos J. Hadziyannis
Academic Department of Medicine, Hippokration General Hospital, 114 Vas. Sophias Ave., 115 27 Athens, Greece
Tel.: +30 1 7774742; fax: +30 1 7706871.
Search for more papers by this authorAbstract
Hepatitis C virus (HCV) is a bloodborne agent transmitted by apparent and inapparent parenteral procedures representing a frequent cause of liver disease world-wide. Both acute and chronic HCV infection may affect the liver as well as various non-hepatic tissues. Numerous extrahepatic disorders have been recognised in association with HCV infection among which dermatological diseases occupy a central part. Cutaneous necrotising vasculitis, mixed cryoglobulinemia, porphyria cutanea tarda and lichen planus are the major skin diseases frequently associated with HCV infection, but other skin disorders, such as Adamantiadis-BehQet syndrome, erythema multiforme and nodosum, malacoplakia, urticaria and pruritus, may also be linked to hepatitis C. Further studies are necessary to establish or refute an aetiopathogenetic role of HCV in these conditions. Skin manifestations are also part of the clinical picture of other extrahepatic disorders associated with HCV infection, such as thyroid dysfunction and HCV-related thrombocytopenia. The response to interferon alpha (a-IFN) therapy in skin diseases is unpredictable with some patients ameliorating, others remaining stationary and others deteriorating.
References
- [1] Alter MJ. Epidemiology of hepatitis C in the West. Semin Liver Dis 1995; 15: 5–14.
- [2] Koff RS, Dienstag JL. Extrahepatic manifestations of hepatitis C and the association with alcoholic liver disease. Semin Liver Dis 1995; 15: 101–109.
- [3] Pawlotsky JM, Ben Yahia M, Andre C, et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994; 19: 841–848.
- [4]
Daoud MS,
Gibson LE,
Daoud S,
El-Azhary RA.
Chronic hepatitis C and skin diseases: a review.
Mayo Clin Proc
1995; 1995: 559–564.
10.4065/70.6.559 Google Scholar
- [5] Parsons ME, Russo GG, Millikan LE. Dermatologic disorders associated with viral hepatitis infections. Int J Dermatol 1996; 35: 77–81.
- [6] Gumber SC, Chopr, S., Hepatitis, C a multifaced disease. Review of extrahepatic manifestations. Ann Intern Med 1995; 123: 615–620.
- [7] Marcellin P, Benhamou J-P. Autoimmune disorders associated with hepatitis C. In: JL Boyer, RK Ockner eds Progress in Liver Diseases, Philadelphia : WB Saunders, 1995; Vol XIII: 2470–267.
- [8] Pawlotsky J-M, Roudot-Thoraval F, Simmonds P, et al. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med 1995; 122: 169–173.
- [9] Lunel F, Musset L. Hepatitis C virus infection and cryoglobulinemia. Viral Hepat Rev 1996; 2: 111–124.
- [10] Hadziyannis SJ. Non-hepatic manifestations and combined diseases in HCV infection. Digest Dis Sci 1996; 41(12): 63S–74S.
- [11] Hadziyannis SJ. The spectrum of extrahepatic manifestations in hepatitis C virus infection. J Viral Hepatitis 1997; 4: 9–28.
- [12] Neumann HA, Barretty DJM, Reinders S, et al. Hepatitis B surface antigen deposition in the blood vessel walls of urticaria lesions in acute hepatitis B. Br J Dermatol 1981; 104: 383–388.
- [13] McElgunn PS. Dermatologic manifestations of hepatitis B infection. J Am Acad Dermatol 1983; 8: 539–548.
- [14] Durand JM, Lefevre P, Harle JR, Boucrat J, Vitviski L, Soubeyrand J. Cutaneous vasculitis and cryoglobulinaemia type II associated with hepatitis C virus infection (letter). Lancet 1991; 337: 499–500.
- [15] Pakula AS, Garden JM, Roth SI. Cryoglobulinemia and cutaneous leukocytoclastic vasculitis associated with hepatitis C virus infection. J Am Acad Dermatol 1993; 28: 850–853.
- [16] Theilmann L, Gmelin K, Kallinowski B, Kommerell B, Koderisch J, Andrassy K. Prevalence of antibodies to hepatitis C virus in sera from patients with systemic necrotizing vasculitis (letter). Nephron 1991; 57: 482.
- [17] Hearth-Holmes M, Zahradka S, Baethge BA, Wolf RE. Leukocytoclastic vasculitis associated with hepatitis C (letter). Am J Med 1991; 90: 765–766.
- [18] Remond B, Reygagne P, Aractingi S, Dubertrer L. Vascu-larite cutance avec cryoglobulinemie mixte au cours d'une hepatite chronique C. Ann Dermatol Venereol 1992; 119: 827–829.
- [19] Durand JM, Kaplanski G, Richard MA, et al. Cutaneous vasculitis in a patient infected with hepatitis C virus: detection of hepatitis C virus RNA in the skin by polymerase chain reaction (letter). Br J Dermatol 1993; 128: 359–360.
- [20] Zimmermann R, Konig V, Bauditz J, Hopf U. Interferon alfa in leukocytoclastic vasculitis, mixed cryoglobulinaemia, and chronic hepatitis C (letter). Lancet 1993; 341: 561–562.
- [21] Levey JM, Bjornsson B, Banner B, et al. Mixed cryoglobulinemia in chronic hepatitis C infection: a clinicopathologic analysis of 10 cases and review of recent literature. Medicine 1994; 73: 53–67.
- [22] Ferri C, Zignego AL, Longombardo G, et al. Effect of alpha-interferon on hepatitis C virus chronic infection in mixed cryoglobulinemia. Infection 1993; 21: 93–97.
- [23] Abel G, Knight GB, Agnello, V., Hepatitis, C virus (HCV) infection of keratinocytes of vasculitis lesions in type II cryoglobulinemia (MC) (abstract). Fifth International Symposium on Hepatitis C Virus and Related Viruses. Gold Coast, 8 August-3 September, Australia 1995: C152.
- [24] 1 Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994; 330: 751–756.
- [25] Meltzer M, Franklin E. Cryoglobulinemia: a study of twenty-nine patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability. Am J Med 1966; 40: 828–836.
- [26] Levo Y, Gorevic PD, Kassab HJ, Tobias H, Franklin EC. Liver involvement in the syndrome of mixed cryoglobulinemia. Ann Intern Med 1977; 87: 287–292.
- [27] Hijikata M, Shimizu YK, Kato H, et al. Equilibrium centri-fugation studies of hepatitis C virus: evidence for circulating immune complexes. J Virol 1993; 67: 1953–1958.
- [28] Ferri C, Greco F, Longombardo G, et al. Association between hepatitis C virus infection in patients with essential mixed cryoglobulinaemia. Ann Intern Med 1992; 117: 573–577.
- [29] Casato M, Taliani G, Pucillo LP, Goffredo F, Lagana B, Bononio L. Cryoglobulinemia and hepatitis C virus. Lancet 1991; 337: 1047–1048.
- [30] Pascual M, Perrin L, Giostra E, Schifferli JA. Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis 1990; 162: 569–570.
- [31] Duclos-Vallee JC, Johanet C, Duron F, Pateron D, Homberg JC, Beaugrand M. Prevalence elevee des anticorps anti-HCV chez les malades atteints de maladie de Hashimoto (abstract). Gastroenterol Clin Biol 1992; 16: A224.
- [32] Misiani R, Bellavita P, Fenili D, et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinaemia. Ann Intern Med 1992; 117: 573–577.
- [33] Marcellin P, Descamps V, Martinot-Peignoux M, et al. Cryoglobulinemia with vasculitis associated with hepatitis C virus infection. Gastroenterology 1993; 104: 272–277.
- [34] Lunel F, Musset L, Cacoub P, et al. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 1994; 106: 1291–1300.
- [35] Galli M, Zehender G, Monti G, et al. Hepatitis C virus RNA in the bone marrow of patients with mixed cryoglobulinemia and in subjects with non-cryoglobulinemia chronic hepatitis type C. J Infect Dis 1995; 171: 672–675.
- [36] Ferri C, La Civita L, Monti M, et al. Can type C hepatitis infection be complicated by malignant lymphoma? (letter). Lancet 1995; 346: 1426–1427.
- [37] Mazzaro C, Tulissi P, Moretti M, et al. Clinical and virolo-gical findings in mixed cryoglobulinaemia. J Int Med 1995; 238: 153–160.
- [38] Lenzi M, Frisoni M, Mantovani V, et al. HLA-B8 confers susceptibility to HCV-related mixed cryoglobulinaemia (abstract). Hepatology 1995; 22(No.4 Pt.2): 353A.
- [39]
Aiyama T,
Yoshioka K,
Okumura A,
Takayanagi M,
Iwata K,
Kakumu S.
Sequence analysis in hypervariable region of HCV in cryoglobulins with chronic HCV disease (abstract).
Hepatology
1995; 22(No.4 Pt.2): 353A.
10.1016/0270-9139(95)95134-2 Google Scholar
- [40] Zignego AL, Cursaro C, Gramenzi A, et al. Hepatitis C virus infection and monoclonal gammopathy (MG): possible role of genotype 2a (abstract). Hepatology 1995; 22(No.4 Pt.2): 353A.
- [41] Zignego AL, Ferri C, Giannini C, et al. Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia. Ann Intern Med 1996; 124: 31–34.
- [42] Kakumu S, Tanaka K, Aiyama T, Imai J, Morishita Y, Fukatsu T. Serum cryoglobulins and chronic hepatitis C virus. Disease among Japanese patients (abstract). Hepatology 1995; 22(No.4 Pt.2): 435A.
- [43] Lunel F, Frangeul L, Poynard T, et al. Multivariate analysis of the potential factors involved in the production of cryoglobulins in HCV infected patients (abstract). Hepatology 1995; 22(No.4 Pt.2): 449A.
- [44] Van Thiel DH, Fagiuoli S, Caraceni P, et al. Cryoglobulinemia: a cause for false negative polymerase chain reaction results in patients with hepatitis C virus positive chronic liver disease. J Hepatol 1995; 22: 464–467.
- [45] Ballare M, Bertoncelli MC, Gnemmi P, et al. Presence and evolution of liver lymphoid aggregates in HCV-associated type II mixed cryoglobulinemia (abstract). Fifth International Symposium on Hepatitis C Virus and Related Viruses. Gold Coast, 28 August-3 September, Australia 1995: C45.
- [46] Freni MA, Artuso D, Gerken G, et al. Focal lymphocytic aggregates in chronic hepatitis C: occurrence, immunohisto-chemical characterization, and relation to markers of autoimmunity. Hepatology 1995; 22: 389–394.
- [47]
Kakumu S,
Alyama T,
Yoshioka K, et al.
Cryoglobulinemia and chronic hepatitis C virus disease among Japanese patients.
Intern Hepatol Commun
1995; 3(Suppl): S49.
10.1016/0928-4346(95)90346-9 Google Scholar
- [48] Hartmann H, Schott P, Polzien F, Mihm S, Ramadori G. Cryoglobulinemia in chronic hepatitis C virus infection: is cross-reactivity of anti-HCV IgM to IgG a pathogenetic mechanism? (abstract). J Hepatol 1995; 25(Supp 1):WP 1/05.
- [49] Cacoub P, Frangeul L, Lunel F, et al. Mixed cryoglobulinemia and hepatitis C virus infection: a multivariate analysis (abstract). Eur J Intern Med 1995; 6(suppl): 54.
- [50] Schirren C-A, Zachoval R, Schirren C-G, Gerbes AL, Pape GR. A role for chronic hepatitis C virus infection in a patient with cutaneous vasculitis, cryoglobulinemia, and chronic liver disease. Digest Dis Sci 1995; 40: 1221–1225.
- [51]
Zenda T,
Okamoto R,
Sanada H, et al.
A possible pathogenic relation between hepatitis C virus and essential cryoglobulinemia, rheumatoid factor and consumption of complement following interferon-beta therapy for chronic active hepatitis C.
Acta Hepatol Japon
1995; 36: 381–385.
10.2957/kanzo.36.381 Google Scholar
- [52] Martins A, Goncalves G, Costa A, Ribeiro S, Reis A. Mixed cryoglobulinemia type III associated to chronic hepatitis C virus infection (abstract). Eur J Intern Med 1995; 6(suppl 1): 71.
- [53] Ferri C, Monti M, La Civita L, et al. Hepatitis C virus infection in non-Hodgkin's B-cell lymphoma complicating mixed cryoglobulinaemia. Eur J Clin Invest 1994, 24: 781–784.
- [54] Zignego AL, Ferri C, Giannini C, et al. HCV infection in B-cell non-Hodgkin's lymphoma (abstract). J Hepatol 1995; 23(suppl 1): 77.
- [55] Franzin F, Ebremov D, Pozzato G, Pussini E, Tulissi P, Burrone O. Monoclonal B-cell expansion, non-Hodgkin's lymphomas and HCV infection (abstract). J Hepatol 1995; 23(Suppl 1): 89.
- [56] De Vita S, Sansonno D, Dolcetti R, et al. Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinaemia. Blood 1995; 86: 1887–1892.
- [57] Agnello V, Abel G, Knight GB, et al. Detection of hepatitis C virus (HCV) in liver, bone marrow, and lymph nodes in type II mixed cryoglobulinemia (MC) using in situ hybridization (abstract). Fifth International Symposium on Hepatitis C Virus and Related Viruses. Gold Coast, 28 August-3 September, Australia 1995: C163.
- [58] Branch AD. Replication of hepatitis C virus: catching it in the act (editorial). Hepatology 1996; 23: 372–375.
- [59] Fargion S, Piperno A, Cappellini MD, et al. Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association. Hepatology 1992; 16: 1322–1326.
- [60] Ferri C, Baicchi U, La Civita L, et al. Hepatitis C virus-related autoimmunity in patients with porphyria cutanea tarda. Eur J Clin Invest 1993; 23: 851–855.
- [61] De Castro M, Sanchez J, Herrera JF, et al. Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda. Hepatology 1993; 17: 551–557.
- [62] Herrero C, Vicente A, Bruguera, M, et al. Is hepatitis C virus infection a trigger of porphyria cutanea tarda Lancet 1993; 314: 788–789.
- [63] Lacour JP, Bodokh I, Castanet J, Beckri S, Ortonne JP. Porphyria cutanea tarda and antibodies to hepatitis C virus. Br J Dermatol 1993; 128: 121–123.
- [64] Koester G, Feldman J, Bigler C. Hepatitis C in patients with porphyria cutanea tarda. J Am Acad Dermatol 1994; 31: 1054.
- [65] Stolzel U, Kostler E, Stoffler-Meilicke M, et al. Hepatitis C virus infection in porphyria cutanea tarda in Germany (abstract). Gastroenterology 1994; 106: A990.
- [66] Navas S, Bosch O, Castillo I, Marriott E, Carreno V. Porphyria cutanea tarda and hepatitis C and B viruses infection: a retrospective study. Hepatology 1995; 21: 279–284.
- [67]
Kondo M,
Horie V,
Okano J, et al.
Porphyria cutanea tarda and HCV infection.
Intern Hepatol Commun
1995; 3(suppl): S45.
10.1016/0928-4346(95)90330-A Google Scholar
- [68] Black MM, Newton, JA., Lichen planus. In: BH Thiers, RC Dob-son eds The Pathogenesis of Skin Disease, New York : Churchill Livingstone, 1986: 85–95.
- [69] Gruppo Italiano Studi Epidemiologici in Dermatologia (GISED). Lichen planus and liver diseases: a multicentre case-control study. Br Med J 1990; 300: 227–230.
- [70] Mokni M, Rybojad M, Puppin, D Jr et al. Lichen planus and hepatitis C virus. J Am Acad Dermatol 1991, 24: 792.
- [71] Agner T, Fogh H, Weismann K. The relation between lichen planus and hepatitis C: a case report. Acta Derm Venereol 1992; 72: 380.
- [72] Doutre MS, Beylot C, Couzigou P, Long P, Royer P, Beylot J. Lichen planus and virus C hepatitis: disappearance of the lichen under interferon alfa therapy (letter). Dermatology 1992; 184: 229.
- [73] Strumia R, Venturini D, Boccia S, Gamberini S, Gullini S. UVA and interferon-alfa therapy in a patient with lichen planus and chronic hepatitis C (letter). Int J Dermatol 1993; 32: 386.
- [74] Boccia S, Gamberini S, Dalla Libera M, Strumia R, Venturini D. Lichen planus and interferon therapy for hepatitis C (letter). Gastroenterology 1993; 105: 1921–1922.
- [75] Cecchi R, Giomi A, Tuci F, Bartoli L, Seghieri G. Pityriasis rubra pilaris, lichen planus, alopecia universalis and vitiligo in a patient with chronic viral hepatitis C. Dermatology 1994; 188: 239–240.
- [76] Papini M, Bruni PL, Bettacchi A, Liberati F. Sudden onset of oral ulcerative lichen in a patient with chronic hepatitis C on treatment with a-interferon (letter). Int J Dermatol 1994; 33: 221–222.
- [77] Protzer U, Ochendorf FR, Leopolder-Ochendorf A, Holter-muller K. Exacerbation of lichen planus during interferon alfa-2a therapy for chronic active hepatitis C. Gastroenterology 1993; 104: 903–905.
- [78] Barreca T, Corsini G, Franceschini R, Gambini C, Garibaldi A, Rolandi E. Lichen planus induced by interferon-alpha-2a therapy for chronic active hepatitis C. Eur J Gastroenterol Hepatol 1995; 7: 367–368.
- [79] Rebora A, Robert E, Rongioletti F. Clinical and laboratory presentation of lichen planus patients with chronic liver disease. J Dermatol Sci 1992; 4: 38–41.
- [80] Divano MC, Parodi A, Rebora A. Lichen planus, liver kidney (LKM-1) microsomal antibodies and hepatitis C virus antibodies. Dermatology 1992; 185: 132–133.
- [81] Grandolfo S, Carbone M, Carozzo M, Gallo V. Oral lichen planus and hepatitis C virus (HCV) infection: is there a relationship? A report of 10 cases. J Oral Pathol Med 1994; 23: 119–122.
- [82] Bellman B, Reddy RK, Falanga V. Lichen planus associated with hepatitis C (letter). Lancet 1995; 346: 1234.
- [83] Jubert C, Pawlotsky JM, Pouget F, Andre C, DeForge L, Bretagne S. Lichen planus and hepatitis C virus-related chronic active hepatitis. Arch Dermatol 1994; 130: 73–76.
- [84] Miinke H, Stockmann F, Ramadori G. Possible association between Behcet's syndrome and chronic hepatitis C virus infection. N Engl J Med 1995; 332: 400–401.
- [86] Antinori S, Esposito R, AHprandi CA, Tadini G. Erythema multiforme and hepatitis C (letter). Lancet 1991; 337: 428.
- [85] Domingo P, Ris J, Martinez E, Casas F. Erythema nodosum and hepatitis C. Lancet 1990; 336:1377.
- [87] Bodokh I, Lacour JP, Perrin C, et al. Cutaneous malacopla-kia associated with chronic hepatitis caused by hepatitis C virus. Ann Dermatol Venereol 1993; 120: 808–810.
- [88] Reichel M, Mauro TM. Urticaria and hepatitis C (letter). Lancet 1990; 336: 822–823.
- [89] Fisher DA, Wright TL. Pruritus as a symptom of hepatitis C. J Am Acad Dermatol 1994; 30: 629–632.
- [90] Lebovics E, Seif F, Kim D, et al. Pruritus in chronic hepatitis C: association with high serum bile acids, advanced pathology and bile duct abnormalities (abstract). Hepatology 1995; 22(No.4 Pt.2): 350A.
- [91] Bonacini M, Govindarajan S. Chronic cholestatic hepatitis C in immunocompromised patients (abstract). Hepatology 1995; 22(No.4Pt.2): 351A.
- [92] Durand JM, Lefevre P, Telle H, Kaplanski G, Guiles N, Soubeyacand J. Thrombocytopenic purpura and hepatitis C virus infection. Haematologia 1993; 78: 135.
- [93] Pawlotsky J-M, Bouvier M, Fromont P, et al. Hepatitis C virus infection and autoimmune thrombocytopenic purpura. J Hepatol 1995; 23: 635–639.
- [94] Pereira J, Accantino L, Alfaco J, Brahm J, Hidalgo P, Mez-zano D. Platelet antibodies in patients with chronic liver disease. Am J Hematol 1995; 50: 173–178.
- [95] Nagamine T, Ohtuka T, Takehara K, Arai T, Takagi H, Mori M. Thrombocytopenia associated with hepatitis C viral infection. J Hepatol 1996; 24: 135–140.
- [96] Shrestha R, McKinley C, Bilir BM, Everson GT. Possible idiopathic thrombocytopenic purpura associated with natural alpha interferon therapy for chronic hepatitis C infection. Am J Gastroenterol 1995; 90: 1146–1147.
- [97] Dourakis S, Deutsch M, Hadziyannis S. Immune thrombocytopenia and a-interferon therapy. J Hepatol 1996; 25: 972–975.
- [98] Durand JM, Cretel E, Retornaz F, Lefevre P, Kaplanski G, Soubeyrand J. Alpha interferon therapy in thrombocytopenia associated with hepatitis C virus infection. J Hepatol 1994; 21: 277–278.
- [99] Bordin G, Ballare M, Bertoncelli MC, Paccagnino L, Zigrossi P, Monteverde A. HCV-associated thrombocytopenia, thrombokinetic study (abstract). Fifth International Symposium on Hepatitis C Virus and Related Viruses. Gold Coast, 28 August-3 September, Australia 1995: C151.
- [100] Fattovich G, Giustina G, Favarato S, Ruol A, Investigators of the Italian Association for the Study of the Liver. A survey of adverse events in 11 241 patients with chronic viral hepatitis treated with alfa interferon. J Hepatol 1996; 24: 38–47.